Dr. Karen Gelmon MD, F.R.C.P.(C)

Clinical Professor Medicine, University of British Columbia

Head, British Columbia Cancer Agency Breast Tumour Group

" Although there have been improvements in survival of breast cancer over the last decade, and many of these improvement directly related to research and new drugs, we need to do better. There are still too many women getting breast cancer and dying of the disease. It is only through more funding and new research initiatives this will happen. The "Passion for Life" program has been promoted by Antoine Gaber whose creativity is known in both artistic and drug development arenas. Creating awareness and raising more funds for breast cancer research through the CBCRA partners will benefit cancer patients now and in the future",said Dr. Karen Gelmon, Head of the Breast Cancer Tumor Group at the British Columbia Cancer Agency, Canada.

BIOGRAPHY:

Dr. Gelmon is a Professor of Medicine at the UBC and a Medical Oncologist at the BCCA, combining clinical and translational research. She is Chair of the Provincial Breast Tumour Group and Clinical leader of Advanced Therapeutics department. She is on the Investigational New Drug Committee and on the Breast Executive Site Committee of the NCIC-CTG. She sits on the International Advisory Board of The Lancet. She is a reviewer for journals and grant review panels, and an active teacher interested in education of health care professionals and the public. She was the recipient of a YWCA Woman of Distinction award in 2003.